CN105663700A - 抗皱美容膏制作方法及其美容膏 - Google Patents
抗皱美容膏制作方法及其美容膏 Download PDFInfo
- Publication number
- CN105663700A CN105663700A CN201511030395.0A CN201511030395A CN105663700A CN 105663700 A CN105663700 A CN 105663700A CN 201511030395 A CN201511030395 A CN 201511030395A CN 105663700 A CN105663700 A CN 105663700A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba leonuri
- component
- wrinkle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000003796 beauty Effects 0.000 title claims abstract description 49
- 239000006071 cream Substances 0.000 title claims abstract description 28
- 238000000034 method Methods 0.000 title claims abstract description 28
- 230000037303 wrinkles Effects 0.000 title abstract description 28
- 239000003814 drug Substances 0.000 claims abstract description 85
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 37
- 229940079593 drug Drugs 0.000 claims abstract description 23
- 239000007788 liquid Substances 0.000 claims abstract description 13
- 230000001954 sterilising effect Effects 0.000 claims abstract description 10
- 238000004821 distillation Methods 0.000 claims abstract description 9
- 238000002156 mixing Methods 0.000 claims abstract description 9
- 241000241413 Propolis Species 0.000 claims abstract description 8
- 239000000284 extract Substances 0.000 claims abstract description 8
- 229940069949 propolis Drugs 0.000 claims abstract description 8
- 241000628997 Flos Species 0.000 claims description 71
- 210000000582 semen Anatomy 0.000 claims description 26
- 230000001153 anti-wrinkle effect Effects 0.000 claims description 23
- 230000008901 benefit Effects 0.000 claims description 21
- 239000000843 powder Substances 0.000 claims description 21
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 18
- 239000000706 filtrate Substances 0.000 claims description 18
- 239000009636 Huang Qi Substances 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 13
- 239000008517 radix Trichosanthis Substances 0.000 claims description 13
- 241000563984 Ampelopsis Species 0.000 claims description 12
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 12
- 238000004321 preservation Methods 0.000 claims description 12
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 11
- 239000000758 substrate Substances 0.000 claims description 10
- 238000004659 sterilization and disinfection Methods 0.000 claims description 9
- 210000001015 abdomen Anatomy 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 8
- 238000002425 crystallisation Methods 0.000 claims description 7
- 230000008025 crystallization Effects 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 229910000831 Steel Inorganic materials 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 230000012010 growth Effects 0.000 claims description 6
- 238000005325 percolation Methods 0.000 claims description 6
- 239000010959 steel Substances 0.000 claims description 6
- 238000000108 ultra-filtration Methods 0.000 claims description 6
- 238000010410 dusting Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 230000002335 preservative effect Effects 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 4
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 3
- 235000011613 Pinus brutia Nutrition 0.000 claims description 3
- 241000018646 Pinus brutia Species 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 238000007598 dipping method Methods 0.000 claims description 3
- 238000002481 ethanol extraction Methods 0.000 claims description 3
- -1 filters Substances 0.000 claims description 3
- 238000011068 loading method Methods 0.000 claims description 3
- 239000012567 medical material Substances 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 210000003491 skin Anatomy 0.000 abstract description 72
- 239000000203 mixture Substances 0.000 abstract description 11
- 230000035876 healing Effects 0.000 abstract description 5
- 102000009123 Fibrin Human genes 0.000 abstract description 4
- 108010073385 Fibrin Proteins 0.000 abstract description 4
- 241000213006 Angelica dahurica Species 0.000 abstract description 3
- 102000008186 Collagen Human genes 0.000 abstract description 3
- 108010035532 Collagen Proteins 0.000 abstract description 3
- 201000010251 cutis laxa Diseases 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 3
- 210000004927 skin cell Anatomy 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 239000013078 crystal Substances 0.000 abstract 3
- 241001313857 Bletilla striata Species 0.000 abstract 2
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 2
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 2
- 229920001436 collagen Polymers 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 238000004382 potting Methods 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 230000007306 turnover Effects 0.000 abstract 1
- 230000008016 vaporization Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 72
- 210000004369 blood Anatomy 0.000 description 68
- 230000000694 effects Effects 0.000 description 53
- 230000017531 blood circulation Effects 0.000 description 32
- 230000001737 promoting effect Effects 0.000 description 27
- 241001465754 Metazoa Species 0.000 description 20
- 210000000952 spleen Anatomy 0.000 description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
- 201000010099 disease Diseases 0.000 description 17
- 238000012360 testing method Methods 0.000 description 16
- 208000002193 Pain Diseases 0.000 description 15
- 239000000463 material Substances 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 14
- 241000699670 Mus sp. Species 0.000 description 13
- 206010030113 Oedema Diseases 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 235000009508 confectionery Nutrition 0.000 description 11
- 229960004756 ethanol Drugs 0.000 description 11
- 230000001815 facial effect Effects 0.000 description 10
- 206010061218 Inflammation Diseases 0.000 description 9
- 208000019255 Menstrual disease Diseases 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 230000002087 whitening effect Effects 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 206010007247 Carbuncle Diseases 0.000 description 8
- 206010013935 Dysmenorrhoea Diseases 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 8
- 208000033809 Suppuration Diseases 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 230000004054 inflammatory process Effects 0.000 description 8
- 240000005373 Panax quinquefolius Species 0.000 description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 description 7
- 238000007596 consolidation process Methods 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 238000005469 granulation Methods 0.000 description 7
- 230000003179 granulation Effects 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 7
- 239000013641 positive control Substances 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 201000000736 Amenorrhea Diseases 0.000 description 6
- 206010001928 Amenorrhoea Diseases 0.000 description 6
- 241000700199 Cavia porcellus Species 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 208000005171 Dysmenorrhea Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 6
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 231100000540 amenorrhea Toxicity 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 235000008434 ginseng Nutrition 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 241000207925 Leonurus Species 0.000 description 5
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 description 5
- 206010027514 Metrorrhagia Diseases 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 206010040829 Skin discolouration Diseases 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 206010040872 skin infection Diseases 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 210000003462 vein Anatomy 0.000 description 5
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- WNGSUWLDMZFYNZ-UHFFFAOYSA-N Leonurine Chemical compound COC1=CC(C(=O)OCCCCN=C(N)N)=CC(OC)=C1O WNGSUWLDMZFYNZ-UHFFFAOYSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 230000003750 conditioning effect Effects 0.000 description 4
- 239000008278 cosmetic cream Substances 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 230000002175 menstrual effect Effects 0.000 description 4
- 230000004089 microcirculation Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 210000004291 uterus Anatomy 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 240000006409 Acacia auriculiformis Species 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 240000001432 Calendula officinalis Species 0.000 description 3
- 235000005881 Calendula officinalis Nutrition 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 208000000616 Hemoptysis Diseases 0.000 description 3
- 206010022998 Irritability Diseases 0.000 description 3
- 208000003351 Melanosis Diseases 0.000 description 3
- 241000037831 Polygonatum sibiricum Species 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 208000004680 Rectal Fistula Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 206010002156 anal fistula Diseases 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000000711 cancerogenic effect Effects 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 210000005069 ears Anatomy 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 231100000682 maximum tolerated dose Toxicity 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 2
- NRTLIYOWLVMQBO-UHFFFAOYSA-N 5-chloro-1,3-dimethyl-N-(1,1,3-trimethyl-1,3-dihydro-2-benzofuran-4-yl)pyrazole-4-carboxamide Chemical compound C=12C(C)OC(C)(C)C2=CC=CC=1NC(=O)C=1C(C)=NN(C)C=1Cl NRTLIYOWLVMQBO-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010007882 Cellulitis Diseases 0.000 description 2
- 206010008570 Chloasma Diseases 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 244000268590 Euryale ferox Species 0.000 description 2
- 235000006487 Euryale ferox Nutrition 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 240000008254 Rosa chinensis Species 0.000 description 2
- 235000000664 Rosa chinensis Nutrition 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 208000032023 Signs and Symptoms Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 231100000315 carcinogenic Toxicity 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000000589 cicatrix Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000002951 depilatory effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229940089161 ginsenoside Drugs 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 230000037308 hair color Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- IRHTZOCLLONTOC-UHFFFAOYSA-N hexacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCO IRHTZOCLLONTOC-UHFFFAOYSA-N 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 229940039009 isoproterenol Drugs 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 230000036559 skin health Effects 0.000 description 2
- 230000036548 skin texture Effects 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- ABTRFGSPYXCGMR-KXQOOQHDSA-N (3R)-beta,psi-caroten-3-ol Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C ABTRFGSPYXCGMR-KXQOOQHDSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- ATWHGWYKSFRYBN-UHFFFAOYSA-N Amygdaloside Natural products O1C(=O)C2(C)CCCC(C3CC4)(C)C2C1OCC3(C1)CC4C1(O)COC1OC(CO)C(O)C(O)C1O ATWHGWYKSFRYBN-UHFFFAOYSA-N 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 244000252230 Artemisia stelleriana Species 0.000 description 1
- 244000237138 Asphodeline lutea Species 0.000 description 1
- 235000000458 Asphodeline lutea Nutrition 0.000 description 1
- 241000092665 Atractylodes macrocephala Species 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 241000167550 Centella Species 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 244000293323 Cosmos caudatus Species 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 235000002673 Dioscorea communis Nutrition 0.000 description 1
- 241000544230 Dioscorea communis Species 0.000 description 1
- 101100117236 Drosophila melanogaster speck gene Proteins 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010052139 Eye oedema Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000366676 Justicia pectoralis Species 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- VELYAQRXBJLJAK-MJSCJBMMSA-N Leonuridine Chemical compound C12C(C)(O)CC(O)C2C=COC1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VELYAQRXBJLJAK-MJSCJBMMSA-N 0.000 description 1
- 240000007890 Leonurus cardiaca Species 0.000 description 1
- 240000003271 Leonurus japonicus Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 241000254023 Locusta Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 208000035753 Periorbital contusion Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 206010068676 Pneumoretroperitoneum Diseases 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 208000005727 Retropneumoperitoneum Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010061577 Ulcer haemorrhage Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 239000004213 Violaxanthin Substances 0.000 description 1
- SZCBXWMUOPQSOX-LOFNIBRQSA-N Violaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C12OC1(C)CC(O)CC2(C)C)C=CC=C(/C)C=CC34OC3(C)CC(O)CC4(C)C SZCBXWMUOPQSOX-LOFNIBRQSA-N 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000006471 dimerization reaction Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- XRRQZKOZJFDXON-UHFFFAOYSA-N nitric acid;silver Chemical compound [Ag].O[N+]([O-])=O XRRQZKOZJFDXON-UHFFFAOYSA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000032361 posttranscriptional gene silencing Effects 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 230000004088 pulmonary circulation Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 235000009514 rubixanthin Nutrition 0.000 description 1
- 239000000455 rubixanthin Substances 0.000 description 1
- ABTRFGSPYXCGMR-SDPRXREBSA-N rubixanthin Natural products O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=C(\CC/C=C(\C)/C)/C)\C)/C)\C)/C)=C(C)C1 ABTRFGSPYXCGMR-SDPRXREBSA-N 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000005982 spleen dysfunction Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 231100000216 vascular lesion Toxicity 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 210000000264 venule Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 235000019245 violaxanthin Nutrition 0.000 description 1
- SZCBXWMUOPQSOX-PSXNNQPNSA-N violaxanthin Chemical compound C(\[C@@]12[C@](O1)(C)C[C@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/[C@]1(C(C[C@@H](O)C2)(C)C)[C@]2(C)O1 SZCBXWMUOPQSOX-PSXNNQPNSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Birds (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种抗皱美容膏制作方法,所述美容膏制作方法包括以下步骤:a.益母草的制作,萃取,作为组分1;b.取薄荷、白术、白芷与白芨用蒸馏法汽化成结晶,粉碎过细筛待用,作为组分2;c.将其余原料药用乙醇提取2次,合并浓缩提取液,作为组分3;d.将组分1、组分2与组分3混合后加基质蜂胶调和,杀菌装罐后冷藏。本发明能刺激深层皮肤细胞更替。益母草可以使皮肤细腻,能使皮肤变柔软,有助于解决皮肤松弛现象,使皮肤光滑有弹性;促进真皮层中胶原蛋白形成,使纤维蛋白再生,重新连接起来,使肌肤达到紧致光滑的效果。还可帮助受损的组织愈合及紧实肌肤。
Description
技术领域
本发明涉及含有来源于植物、动物或矿物组份的美容配制品,特别涉及一种益母草抗皱美容膏及其制作方法。
背景技术
中药美容是在中医中药基础理论的指导下,通过使用美容中药内服或外用来恢复或提高机体的生理功能的一种方法。内服法从内部补益气血、调节脏腑功能,使人气血充沛,容光焕发。外用法是运用药物直接作用于体表局部,它利用药物的性能,使气血流动、经气畅通,以达到美容防衰的功效。与化学化妆品相比较,中药美容具有显著的特点与优势。一是中药美容与中医药融为一体,具有明显的功能性,其原理跟中医学一样,注重整体的调理,强调先调理内在,然后就会形之于外,因此,美容效果持久、稳定。二是以中医理论为指导,具有中医理论特征,如整体观念、辨证论治、药性理论、复方配伍,具有与现代化妆品不同的思路。三是具有纯天然性,中药在美容防晒方面较化学合成品具有独特和显著的优势,具有无毒、无害、不致癌等特点。
迄今为止总结出来的美容中药共300多种,美容药方近千种,其精华可为现代美容提供行之有效的天然药物疗法。当归、人参、白芷、薏苡仁、杏仁、桃仁、枸杞、黄柏、菊花、白附子、川芎、百合、丹参、芡实等都是较常用的美容中药。其中当归性温,味甘、辛。具有活血、补血的功效,能加快血液循环,营养皮肤,使皮肤健康红润。人参含有挥发油,人参皂苷,多糖,多种低分子肽氨基酸,B族维生素、维生素C等成分,能改善局部皮肤的血液循环,加强皮肤营养物质的供应,促进皮肤的新陈代谢,保持皮肤的光洁和滋润,因而可以起到延缓皮肤衰老的作用。
珍珠自古至今一直是人们喜爱的护肤驻颜美容佳品,能使肌肤细腻,颜色红润,无皱纹。据传清代慈禧太后就常吞服月季花以驻颜美容。淮山、莲子、百合、红枣均能健脾养胃,养血安神,使得肌肤润泽健美。红花、桃仁等活血化淤药有改善皮肤微循环作用,从而使人的气血充盛,容光焕发。三七、丹参能滋润和清洁皮肤,祛除皮肤黄褐斑和黑斑,抑制脂溢性皮炎,对皮肤有延缓衰老作用。应用中药进行美容,内服的有汤剂、散剂、膏剂、酒剂,以及美容药膳等。生活中药膳美容应用较多,其实这是基于中医“医食同源、药食同源”的理论,选用某些作用相关的药物和食物配制成食品,以达到美容和保健的双重功效。外用有洗、熏,以及面膜敷等,又以面膜应用较多。
益母草,又名:蓷、茺蔚、坤草、九重楼、云母草、森蒂[1],拉丁学名:Leonurusartemisia(Laur.)S.Y.HuF,为唇形科、益母草属植物,夏季开花。其干燥地上部分为常用中药,中国大部分地区均产,生用或熬膏用。一年或二年生草本全国大部分地区均有分布,生于山野荒地、田埂、草地等。在夏季生长茂盛花未全开时采摘,味辛苦、凉,活血、祛淤、调经、消水,治疗妇女月经不调,胎漏难产,胞衣不下,产后血晕,瘀血腹痛,崩中漏下,尿血、泻血,痈肿疮疡。
益母草有利尿消肿、收缩子宫作用的作用,是历代医家用来治疗妇科病的要药。益母草可全草入药,有效成分为益母草素,益母草含益母草碱、水苏碱、益母草定、益母草宁等多种生物碱及苯甲酸、氯化钾等。
益母草制剂有兴奋动物子宫的作用,与脑垂体后叶素相似,益母草浸膏及煎剂对子宫有强而持久的兴奋作用,不但能增强其收缩力,同时能提高其紧张度和收缩率。
益母草,又名茺蔚,坤草,是一种草本植物,苦、辛,微寒。由于它含有硒和锰等微量元素,可抗氧化、防衰老、抗疲劳及抑制癌细胞增生,因此,有养颜功效。
本发明公开了一种中药抗皱组合物,由中药成份组成。其中,当归促进皮肤代谢、活血亮肤;白芷、白茯苓、杏仁美白润肤;白芨紧实除皱;月季花有美白收敛生肌、促进细胞再生及疤痕愈合的功效,是美白护肤的珍品;益母草能抗老化、紧实毛孔、除细纹的功效,也是美容抗老的圣品。有活血亮肤、美白防皱的功效,适用于中老年,衰老松弛、皱纹密布的皮肤。
发明内容
本发明所要解决的技术问题在于,中药美容是在中医中药基础理论的指导下,通过使用美容中药内服或外用来恢复或提高机体的生理功能的一种方法。内服法从内部补益气血、调节脏腑功能,使人气血充沛,容光焕发。外用法是运用药物直接作用于体表局部,它利用药物的性能,使气血流动、经气畅通,以达到美容防衰的功效。与化学化妆品相比较,中药美容具有显著的特点与优势。益母草能抗老化、紧实毛孔、除细纹的功效,也是美容抗老的圣品。有活血亮肤、美白防皱的功效,适用于中老年,衰老松弛、皱纹密布的皮肤。
为解决这些技术难题,本发明提供了一种益母草抗皱美容膏,其所述美容膏中可以包括以下重量份数的原料药:益母草10~50份,积雪草10~20份,黄芪10~20份,玉竹10~20份,葛根10~20份,丹参10~20份,黄精10~20份,天花粉10~20份,红花10~20份,白芍10~20份,白芨10~20份,薄荷10~20份,白茯苓10~20份,白蔹10~20份,白芷10~20份,月季花10~20份,金盏花10~20份,当归10~20份,杏仁10~20份,玫瑰花10~20份,天竺葵10~20份,合欢皮10~20份,白术10~20份,冬瓜皮10~20份。
所述益母草抗皱美容膏,其所述美容膏中还可以包括以下重量份数的原料药:益母草10~30份,积雪草10~15份,黄芪10~15份,玉竹10~15份,葛根10~15份,丹参10~15份,黄精10~15份,天花粉10~15份,红花10~15份,白芍10~15份,白芨10~15份,薄荷10~15份,白茯苓10~15份,白蔹10~20份,白芷10~20份,月季花10~20份,金盏花10~20份,当归10~20份,杏仁10~20份,玫瑰花10~20份,天竺葵10~20份,合欢皮10~20份,白术10~20份,冬瓜皮10~20份。
所述益母草抗皱美容膏,其所述美容膏中也可以包括以下重量份数的原料药:益母草10~40份,积雪草10~20份,黄芪10~20份,玉竹10~20份,葛根10~20份,丹参10~20份,黄精10~20份,天花粉10~20份,红花10~20份,白芍10~20份,白芨10~20份,薄荷10~20份,白茯苓10~20份,白蔹10~15份,白芷10~15份,月季花10~15份,金盏花10~15份,当归10~15份,杏仁10~15份,玫瑰花10~15份,天竺葵10~15份,合欢皮10~15份,白术10~15份,冬瓜皮10~15份。
为解决上述技术问题,本发明还提供一种益母草抗皱美容膏的制作方法,其所述美容膏制作方法包括以下步骤:
a.益母草的制作,萃取,作为组分1;
b.取薄荷、白术、白芷与白芨用蒸馏法汽化成结晶,粉碎过细筛待用,作为组分2;
c.将其余原料药用乙醇提取2次,合并浓缩提取液,作为组分3;
d.将组分1、组分2与组分3混合后加基质蜂胶调和,杀菌装罐后冷藏。
所述步骤a中,可以在夏季生长茂盛花未全开时采摘,将采摘好的益母草晒干,切碎,过80-100目筛。
所述步骤a中,进一步包括萃取的步骤,将切碎的益母草置于有盖不锈钢桶内,加70%乙醇液,质量为粗粉的0.8-1倍,搅拌均匀,湿润密闭放置1小时以上,使充分膨胀;将渗漉筒底部滤板用纱布袋包裹铺平后再将湿润膨胀后的药物样品拌松弄散,然后用不锈钢勺盛粉,均匀的装入渗漉筒,装10-12厘米厚,用T型棒压匀,再按上述操作,一层一层的装入,适当加压,药粉填装不得超过渗漉筒的2/3高处;药粉面上盖不锈钢孔板压牢,打开渗漉筒下面的放料阀,并放一容器,然后缓缓加入70%乙醇液;待排出药粉粉粒之间的空气,并有乙醇流出约20L左右,关闭放料阀,盖上漉筒、浸渍24小时,然后开放料阀进行渗漉,控制渗漉速度一般为1000g药材每分钟流出2~3ml,滤液放入贮液缸内,并将排空时的乙醇液倒入贮液缸;将渗滤液合并静置,加热浓缩至膏状,静置备用,成组分1。
所述步骤b中,可以取薄荷、白术、白芷与白芨用蒸馏法汽化成结晶,粉碎过120-150目细筛待用,作为组分2。
所述步骤c中,可以将所述其余原料加入占其质量5-10倍量的乙醇浸泡4-6小时,加热提取2次,每次1-2小时,合并提取液,静置后去上清液,然后100-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.25的滤液,静置放入双效真空浓缩器中混合,先将滤液浓缩至80℃时相对密度为1.32的浓缩液,再置入0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含0.1g浸膏,作为组分3。
所述步骤d中,可以将上述步骤提取的三种组分混合,搅拌均匀,加热,调和基质,基质选用蜂胶,紫外线杀菌装瓶冷藏。
所述益母草抗皱美容膏的使用方法,由于本抗皱美容膏不含防腐剂,所以必须冷藏,每次临睡前洁面后,将抗皱膏均匀涂抹于脸部,并用中指指肚在脸部按摩15-20分钟,至其充分吸收后,第二天早起洗去即可。
益母草,又名茺蔚,坤草,是一种草本植物,苦、辛,微寒。由于它含有硒和锰等微量元素,可抗氧化、防衰老、抗疲劳及抑制癌细胞增生,因此,有养颜功本发明参考古今中医学药理研究成就,筛选滋润肌肤、补气活血、清肝明目、滋肝补肾、明目退翳、平肝潜阳、消肿除水的天然中药,扶正祛邪,通腑泄毒,活血散瘀,调节人体的新陈代谢机能,提高人体脸部皮肤血液循环,从而达到去除皱纹,紧致肌肤,消除皮肤纹理,消肿祛瘀、缓解疲劳、紧致眼周肌肤、淡化眼袋,减少皱纹、美化容貌的目的。本发明能刺激深层皮肤细胞更替。本发明能使皮肤变柔软,有助于解决皮肤松弛现象,使皮肤光滑有弹性;促进真皮层中胶原蛋白形成,使纤维蛋白再生,重新连接起来,使肌肤达到紧致光滑的效果。还可帮助受损的组织愈合及紧实肌肤。
具体实施方式
中药美容是在中医中药基础理论的指导下,通过使用美容中药内服或外用来恢复或提高机体的生理功能的一种方法。内服法从内部补益气血、调节脏腑功能,使人气血充沛,容光焕发。外用法是运用药物直接作用于体表局部,它利用药物的性能,使气血流动、经气畅通,以达到美容防衰的功效。与化学化妆品相比较,中药美容具有显著的特点与优势。一是中药美容与中医药融为一体,具有明显的功能性,其原理跟中医学一样,注重整体的调理,强调先调理内在,然后就会形之于外,因此,美容效果持久、稳定。二是以中医理论为指导,具有中医理论特征,如整体观念、辨证论治、药性理论、复方配伍,具有与现代化妆品不同的思路。三是具有纯天然性,中药在美容防晒方面较化学合成品具有独特和显著的优势,具有无毒、无害、不致癌等特点。
迄今为止总结出来的美容中药共300多种,美容药方近千种,其精华可为现代美容提供行之有效的天然药物疗法。当归、人参、白芷、薏苡仁、杏仁、桃仁、枸杞、黄柏、菊花、白附子、川芎、百合、丹参、芡实等都是较常用的美容中药。其中当归性温,味甘、辛。具有活血、补血的功效,能加快血液循环,营养皮肤,使皮肤健康红润。人参含有挥发油,人参皂苷,多糖,多种低分子肽氨基酸,B族维生素、维生素C等成分,能改善局部皮肤的血液循环,加强皮肤营养物质的供应,促进皮肤的新陈代谢,保持皮肤的光洁和滋润,因而可以起到延缓皮肤衰老的作用。
中医气血理论认为,气血循环过程是人体一切组织器官进行工作的物质基础,气血以流畅平衡为贵,如果气血不流畅就会产生瘀血,瘀血阻于体内,将进一步导致气血循环的恶化,造成更严重的瘀塞,故中医以气血为纲,通过调气活血使之流畅平衡,可祛病强身、养血美容。皮肤斑点之根本在瘀,退斑必先祛瘀、祛瘀当须活血,活血更须补气、理气,气为血之帅,血随之而运行;血为气之守,气得之而静谧,气结则血凝,气虚则血脱,气迫则血走。气血和则俱和。而理气在肝,补气在肺肾,肺主皮毛。因气滞血瘀,影响到肺脾肝肾的气血运行功能,而致面部出现黄褐斑、黑眼圈、眼袋、眼部浮肿、雀斑等色斑,甚至出现头发脱落、斑秃。
益母草的作用:对子宫的作用:益母草煎剂、乙醇浸膏及益母草碱对兔、猫等多种动物的离体子宫有兴奋作用。
抗血小板聚集及抗血栓形成:体外实验证明,益母草及其提取物有拮抗ADP诱导的正常动物血小板聚集作用。体内实验亦证明益母草能显著减少外周循环中的血小板总数和肺泡壁毛细血管内血小板及其聚集物。益母草对兔肺循环红色血栓有显著溶解作用。此外,益母草还有增强机体的细胞免疫等作用。
具有改善冠脉循环和保护心脏的作用:益母草可促进由异丙肾上腺素造成的局部血流微循环障碍的很快恢复。对心血管的作用:益母草对离体豚鼠心脏,用异丙肾上腺素造成心肌缺血模型,能显著增加冠脉流量及相当显著地减慢心率。静注益母草制剂使麻醉犬明显增加冠脉流量,降低冠脉阻力,减慢心率及减少输出量和左心室作功的作用。
积雪草具有清热解毒,利湿消肿、滋补、消炎、镇定的作用。能刺激深层皮肤细胞更替。积雪草可以紧致表皮与真皮连接部分,能使皮肤变柔软,有助于解决皮肤松弛现象,使皮肤光滑有弹性;促进真皮层中胶原蛋白形成,使纤维蛋白再生,重新连接起来,使肌肤达到紧致光滑的效果。还可帮助受损的组织愈合及紧实肌肤。既能促进表皮与真皮之间的密切连接,又能抑制脂肪细胞的增加,防止皮肤水肿、出现肥胖。积雪草适用于各种肤质,其幼芽的水提取物具有抗菌消炎的作用,其属双子叶植物伞形科,能消肿解毒祛脓疮。
黄芪以补虚为主,能补气固表,利尿托毒,排脓,敛疮生肌。用于气血不足、疮疡内陷、脓成不溃或久溃不敛者。黄芪具有很好的托毒生肌的功能,即久不愈合的脓肿化脓生肌。现代医学研究表明,黄芪内含而多种抗菌有效成分,而且能增强机体的免疫功能,因此还能用于预防某些传染病的发生。《本草逢原》载:“黄芪能补五脏诸虚,治脉弦自汗,泻阴火,去肺热,无汗则发,有汗则止。”是增进抵抗力和防御疾病的良药。
白芍入肝、脾经,养血柔肝,缓中止痛,敛阴收汗。治胸腹胁肋疼痛,泻痢腹痛,自汗盗汗,阴虚发热,月经不调,崩漏,带下,妇人血闭不通,消瘀血,能蚀脓,益女子血。《日华子本草》:治风、补劳,主女人一切病,并产前后诸疾,通月水,退热,除烦,益气,天行热疾,瘟瘴,惊狂,妇人血运,及肠风,泻血,痔瘘。发背,疮疥,头痛,明目,目赤努肉。赤色者多补气,白者治血。
白芨性苦、甘、涩,微寒。归肺、肝、胃经。功能主治收敛止血,消肿生肌。用于咳血吐血,外伤出血,疮疡肿毒,皮肤皲裂;肺结核咳血,溃疡病出血。《神农本草经》:“主痈肿、恶疮、败疽,伤阴死肌,胃中邪气”;《本草纲目》:“气味(根)苦、平、无毒。
白芷性味归经:辛,温。归肺、胃经。祛风散寒,通窍止痛,消肿排脓,燥湿止带。《日华子本草》:治目赤胬肉,及补胎漏滑落,破宿血,补新血,乳痈、发背、瘰疬、肠风、痔瘘,排脓,疮痍、疥癣,止痛生肌,去面皯疵瘢。
丹参苦,微寒。归心、肝经。祛瘀止痛,活血通经,清心除烦。用于月经不调,经闭痛经,症瘕积聚,胸腹刺痛,热痹疼痛,疮疡肿痛,心烦不眠。用于胸肋胁痛,风湿痹痛,症瘕结块,疮疡肿痛,跌仆伤痛,月经不调,经闭痛经,产后瘀痛等。治疗胸肋疼痛、症瘕结块,以及月经不调、经闭经痛具有良效。《纲目》载:丹参,按《妇人明理论》云,四物汤治妇人病,不问产前产后,经水多少,皆可通用,惟一味丹参散,主治与之相同。盖丹参能破宿血,补新血,安生胎,落死胎,止崩中滞下,调经脉。丹参主要成分丹参酮有扩张血管、改善循环、解除血管内凝血等作用,具有活血化痕之功效,并能促进肝脏血液循环,利于肝细胞再生。
金盏花,拉丁名(Calendulaofficinalis),又名金盏菊、常春花。金盏菊富含多种维生素,尤其是维生素A和维生素C,可预防色素沉淀、增进皮肤光泽与弹性、减缓衰老、避免肌肤松弛生皱。也可预防文明病,如血管病变及癌症,更能理气止咳、健胃、化痰、预防哮喘及支气管炎。几乎各部位都可以食用;其花瓣有美容之功能,花含类胡萝卜素、番茄烃、蝴蝶梅黄素、玉红黄质、挥发油、树脂、黏液质、苹果酸等。根含苦味质,山金东二醇;种子含甘油酯、蜡醇和生物碱。放入洗发精里可以使得头发颜色变淡。
薄荷,土名叫“银丹草”,为唇形科植物,即同属其他干燥全草,多生于山野湿地河旁,根茎横生地下,是一种有特种经济价值的芳香作物。全株青气芳香。叶对生,花小淡紫色,唇形,花后结暗紫棕色的小粒果。薄荷是中华常用中药之一。它是辛凉性发汗解热药,治流行性感冒、头疼、目赤、身热、咽喉、牙床肿痛等症。处用可治神经痛、皮肤瘙痒、皮疹和湿疹等。薄荷是中国常用中药,幼嫩茎尖可作菜食,全草又可入药,治感冒发热喉痛,头痛,目赤痛,肌肉疼痛,皮肤风疹搔痒,麻疹不透等症,此外对痈、疽、疥、癣、漆疮亦有效。薄荷含有薄荷醇,该物质可清新口气并具有多种药性,可缓解腹痛、胆囊问题如痉挛,还具有防腐杀菌、利尿、化痰、健胃和助消化等功效。大量食用薄荷可导致失眠,但小剂量食用却有助于睡眠。
红花(拉丁学名:CarthamustinctoriusL.),别名:红蓝花、刺红花,菊科、红花属植物,干燥的管状花,橙红色,花管狭细,先端5裂,裂片狭线形,花药黄色,联合成管,高出裂片之外,其中央有柱头露出。具特异香气,味微苦。以花片长、色鲜红、质柔软者为佳。活血通经,散瘀止痛,有助于治经闭、痛经、恶露不行、胸痹心痛、瘀滞腹痛、胸胁刺痛、跌打损伤、疮疡肿痛疗效。有活血化瘀,散湿去肿的功效。
白蔹为葡萄科植物白蔹的根,每年春、秋季采挖,除去茎及细须根,洗净后多纵切成两瓣、四瓣或斜片,晒干即可入药。其性凉,味苦甘辛,具有清热、解毒、散结、生肌、止痛的功效,用于治疗痈肿、疔疮、瘰疬、烫伤、温疟、惊痫、血痢、肠风、痔漏等症。
天花粉,中药名。《本草正义》:药肆之所谓天花粉者,即以萎根切片用之,有粉之名,无粉之实。天花粉为葫芦科植物栝蒌的根,是一种中药,为清热泻火类药物,其具体功效是清热泻火,生津止渴,排脓消肿。主治:治热病口渴、消渴、黄疸、肺燥咳血、痈肿、痔痿。对于治疗糖尿病,常用它与滋阴药配合使用,以达到标本兼治的作用。
当归补血;活血;调经止痛;润燥滑肠。主血虚诸证;月经不调;经闭;痛经;症瘕结聚;崩漏;虚寒腹痛;痿痹;肌肤麻木;肠燥便难;赤痢后重;痈疽疮疡;跌扑损伤。祖国医学认为,当归味甘而重,故专能补血,其气轻而辛,故又能行血,补中有动,行中有补,为血中之要药。因而,它既能补血,又能活血,既可通经,又能活络。凡妇女月经不调,痛经,血虚闭经,面色萎黄,衰弱贫血,子宫出血,产后瘀血,例经(月经来潮时,出现口鼻流血)等妇女的常见病,都可以用当归治疗。当归是中医中的最常用药多用于煲汤,特别对贫血患者是最好的。还能显著促进机体造血功能,升高红细胞、白细胞和血红蛋白含量
月季花可提取香料。根、叶、花均可入药,具有活血消肿、消炎解毒功效。而且是一味妇科良药。中医认为,月季味甘、性温,入肝经有活血调经、消肿解毒之功效。由于月季花的祛瘀、行气、止痛作用明显,故常被用于治疗月经不调、痛经等病症。月经过多、白带多,用月季花(或根)15g水煎服或炖猪肉食;月季花10g、大枣12g同煎,汤成后加适量蜂蜜服用,此方又香又甜,不像是药,对经期潮热很有效。此外,女性常用月季花瓣泡水当茶饮,或加入其他健美茶中冲饮,还可活血美容,使人青春长驻。
玫瑰花:《本草正文》中道:“玫瑰花,清而不浊,和而不猛,柔肝醒胃,疏气活血,宣通窒滞而绝无辛温刚燥之弊,断推气分药之中,最有捷效而最驯良,芳香诸品,殆无其匹”玫瑰花中含有300多种化学成份,如芳香的醇、醛、脂肪酸、酚和含香精的油和脂,常食玫瑰制品中以柔肝醒胃,舒气活血,美容养颜,令人神爽。玫瑰初开的花朵及根可入药,有理气、活血、收敛等作用、主治月经不调,跌打损伤、肝气胃痛,乳臃肿痛等症。玫瑰果的果肉,可制成果酱,具有特殊风味,果实含有丰富的维生素C及维生素P,可预防急、慢性传染病、冠心病、肝病和阻止产生致癌物质等。用玫瑰花瓣以蒸馏法提炼而得的玫瑰精油(称玫瑰露),可活化男性荷尔蒙及精子。玫瑰露还可以改善皮肤质地,促进血液循环及新陈代谢。
葛根,中药名。为豆科植物野葛的干燥根,习称野葛。秋、冬二季采挖,趁鲜切成厚片或小块;干燥。甘、辛,凉。有解肌退热,透疹,生津止渴,升阳止泻之功。常用于表证发热,项背强痛,麻疹不透,热病口渴,阴虚消渴,热泻热痢,脾虚泄泻。《本草经疏》:“葛根,解散阳明温病热邪主要药也,故主消渴,身大热,热壅胸膈作呕吐。发散而升,风药之性也,故主诸痹。”“伤寒头痛兼项强腰脊痛,及遍身骨疼者,足太阳也,邪犹未入阳明,故无渴证,不宜服。”
杏仁是蔷薇科杏的种子,分为甜杏仁和苦杏仁,主要含有蛋白质、脂肪、糖、微量苦杏仁苷。脂肪的组成中主要是油酸和亚油酸。杏仁果长在短距(shortspur)上,具有未成熟的外观。当果实成熟时,它绿色的外壳会裂开,而显露出包在粗糙外壳中的核仁,核仁为黄色且有很多小洞,外壳为坚硬的木质。杏仁果为扁平卵形,一端圆,另一端尖,覆有褐色的薄皮。核仁含有20%的蛋白质,不含淀粉,磨碎、加压后,榨出的油脂,大约是本身重量的一半,杏仁油为淡黄色,虽然没有香味,但具有软化皮肤和美容的功效。
合欢皮为豆科(Legumin0sae)植物合欢的干燥树皮,多于夏秋季节剥取,晒干而成[1]。呈卷曲筒状或半筒状,长40~80cm,厚合欢皮0.1~0.3cm。外表面灰棕色至灰褐色,性味甘、平。有解郁、和血、宁心、消痈肿之功。有治心神不安、忧郁、失眠、肺痈、痈肿、瘰疠、筋骨折伤之效。落叶乔木,伞形树冠。叶互生,伞房状花序,雄蕊花丝犹如缕状,半白半红,故有“马缨花”、“绒花”之称。
黄精黄精(学名:Polygonatumsibiricum),又名:鸡头黄精、黄鸡菜、笔管菜、爪子参、老虎姜、鸡爪参。为黄精属植物,根茎横走,圆柱状,结节膨大。叶轮生,无柄。药用植物,具有补脾,润肺生津的作用。补中益气、润泽皮肤等功效,适合于心血管系统病患者服食。
冬瓜皮味甘,性凉。归经归脾、小肠经。功效利尿消肿。主治用于水肿胀满,小便不利,暑热口渴,小便短赤。《本草纲目》:冬瓜皮(折伤,烧研、酒服)治血滞腰酸痛。《本草再新》:走皮肤,去湿追风,补脾泻火。
白茯苓性味归经:甘;淡;平。心;脾;肺;肾经。渗湿利水;健脾和胃;宁心安神。用于小便不利;水肿胀满;痰饮咳逆;呕吐;脾虚食少;泄泻;心悸不安;失眠健忘;遗精白浊。用于脾虚泄泻,白茯苓既能健脾,又能渗湿,对于脾虚运化失常所致泄泻、带下,应用白茯苓有标本兼顾之效,白茯苓常与党参、白术、山药等配伍。白茯苓又可用为补肺脾,治气虚之辅佐药。用于心悸,失眠等症茯苓能养心安神,故可用于心神不安、心悸、失眠等症,白茯苓常与人参、远志、酸枣仁等配伍。用于痰饮咳嗽,痰湿入络,肩背酸痛茯苓既能利水渗湿,又具健脾作用,对于脾虚不能运化水湿,停聚化生痰饮之症,具有治疗作用。
白术,拉丁学名Atractylodesmacrocephala。别名桴蓟,于术,冬白术,淅术,杨桴,吴术,片术、苍术等,属于菊科、苍术属多年生草本植物。喜凉爽气候,以根茎入药,具有多项药用功能。主要分布于四川、云南、贵州等山区湿地。白术具有健脾益气,燥湿利水,止汗,安胎的功效,用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。《医学启源》记载:“除湿益燥,和中益气,温中,去脾胃中湿,除胃热,强脾胃,进饮食,安胎。”
实施例1
在夏季生长茂盛花未全开时采摘,将采摘好的益母草晒干,干燥制作,泡入乙醇萃取,作为组分1;
取薄荷、白术、白芷与白芨用蒸馏法汽化成结晶,粉碎过细筛待用,作为组分2;
将其余原料积雪草,黄芪,玉竹,葛根,丹参,黄精,天花粉,红花,白芍,白茯苓,白蔹,月季花,金盏花,当归,杏仁,玫瑰花,天竺葵,合欢皮,冬瓜皮用乙醇提取2次,合并浓缩提取液,作为组分3;
将组分1、组分2与组分3混合后加基质蜂胶调和,紫外线杀菌装罐,本发明不含防腐剂,必须冷藏。
实施例2:
在夏季生长茂盛花未全开时采摘,将采摘好的益母草晒干,将晾晒好的益母草3500g切碎,过100-120目筛,将切碎的益母草置有盖不锈钢桶内,加70%乙醇液,质量为粗粉的0.8-1倍,搅拌均匀,湿润密闭放置1小时以上,使充分膨胀;将渗漉筒底部滤板用纱布袋包裹铺平后再将湿润膨胀后的药物样品拌松弄散,然后用不锈钢勺盛粉,均匀的装入渗漉筒,装10-12厘米厚,用T型棒压匀,再按上述操作,一层一层的装入,适当加压,药粉填装不得超过渗漉筒的2/3高处;药粉面上盖不锈钢孔板压牢,打开渗漉筒下面的放料阀,并放一容器,然后缓缓加入70%乙醇液;待排出药粉粉粒之间的空气,并有乙醇流出约20L左右,关闭放料阀,盖上漉筒、浸渍24小时,然后开放料阀进行渗漉,控制渗漉速度一般为1000g药材每分钟流出2~3ml,滤液放入贮液缸内,并将排空时的乙醇液倒入贮液缸;将渗滤液合并静置。加热浓缩至膏状,静置备用,成组分1。将薄荷1000g、白术1000g、白芷1000g和白芨1000g用蒸馏法汽化成结晶,粉碎待用,为组分2;再将其他原料积雪草1000g,黄芪1000g,玉竹1000g,葛根1000g,丹参1000g,黄精1000g,天花粉1000g,红花1000g,白芍1000g,白茯苓1000g,白蔹1000g,月季花1000g,金盏花1000g,当归1000g,杏仁1000g,玫瑰花1000g,天竺葵1000g,合欢皮1000g,冬瓜皮1000g,加入占其质量5-10倍量的乙醇浸泡4-6小时,加热提取2次,每次1-2小时,合并提取液,静置后去上清液,然后100-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.25的滤液,静置备用。将上述步骤提取的两种滤液,放入双效真空浓缩器中混合,先将滤液浓缩至80℃时相对密度为1.32的浓缩液,再置入0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含0.1g浸膏,成组分3。将组分1投入组分2中组分3,搅拌均匀,加热,调和基质蜂胶,紫外线杀菌装罐,本发明不含防腐剂,必须冷藏。
实施例3
在夏季生长茂盛花未全开时采摘,将采摘好的益母草晒干,将晾晒好的益母草4000g浸泡水中12小时,然后放入提取罐加热煮沸1小时,过滤,滤液备用;滤渣加水,第二次加热,煮沸45分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸半小时,过滤;将三次滤液合在一起,用纱布过滤,残渣中加入50-60%乙醇,60℃-70℃继续浸提2h,每10min搅拌一次,纱布过滤,合并浸提液,成组分1;薄荷1000g、白术1100g、白芷1000g和白芨1100g用蒸馏法汽化成结晶,粉碎待用,为组分2;再取积雪草1200g,黄芪1200g,玉竹1200g,葛根1100g,丹参1200g,黄精1200g,天花粉1100g,红花1200g,白芍1100g,白茯苓1200g,白蔹1200g,月季花1100g,金盏花1200g,当归1200g,杏仁1200g,玫瑰花1100g,天竺葵1100g,合欢皮1100g,冬瓜皮1200g,用水浸泡,加热煮沸3次,每次1-2小时,过滤,滤液备用;将合并后3次的滤液抽入减压浓缩罐内,减压浓缩至相对密度为1.20,温度至60℃-70℃的浸膏;成为组分3,混合组分1和组分2组分3,调和基质,成凝胶剂;所述基质选自:蜂胶。紫外线杀菌装罐,本发明不含防腐剂,必须冷藏。
药理学毒性试验
毒理学试验:
试验例1:本发明急性毒性试验
一、试验材料:
动物:昆明种小鼠,体重21-24g,雌雄各半,山东大学生物试验室育种。药物:本发明美容霜。
二、方法:
1、LD50计算:采用改良寇氏法,将小鼠随机分成5组,每组10只,雌雄各半,将洗液剂溶解,配成最大浓度,按小鼠最大允许容量给药,所给剂量按生药量依次为18,14.4,11.5,9.2,7.4(g.kg-1),在动物禁食(不禁水)18小时后,一日内分两次给药(间隔半小时),每次0.5ml,观察动物死亡情况。
2、最大耐受剂量测定(MTD值):取小鼠20只,雌雄各10只。将片剂加蒸馏水溶解,配成最高浓度,按动物的最大耐受量,以注射灌喂器能抽动为准。在动物禁食(不禁水)18小时后,一日内分两次给药(间隔半小时),每次0.5ml(每ml含生药0.36g),总药量为18g生药/kg.d,相当临床成人50Kg体重用量的300倍。给药后连续观察7天。
三、试验结果:
在LD50计算中当用最大允许浓度和最大允许容量给予小鼠时(18g/Kg.d),未见小鼠死亡,即未测出LD50,只可求最大耐受剂量,在7天观察期中,动物其食欲、活动、毛色、精神状态等皆正常,发育正常,未见有死亡。即选用相当于临床剂量的300倍药量,并无不良反应发生,表明急性毒性极小,MTD>18g/Kg.d。
试验例2:本发明急性皮肤刺激试验报告
1、实验目的:检测本发明对实验动物皮肤的刺激/腐蚀作用和强度
2、材料和方法:
2.1.受试物名称:本发明美容霜(实施例方法2制得)
2.2.实验动物:壹级大耳白种家兔,10只,雌性,体重2.1-2.3kg;由青岛大学医学院生物系实验动物中心提供;
2.3.试验方法:
选用皮肤完好的健康家兔10只,于试验前24小时将其背部脊柱两侧被毛剪掉,去毛面积左、右各约4cm×4cm。试验时取受试物0.2ml涂于2.5cm×2.5cm的二层纱布上,敷贴于一侧去毛皮肤表面,油纸覆盖,胶布固定。另一侧皮肤作为空白对照。封闭4小时后,去除覆盖物,并用温水清洗去残留受试物,于去除受试物后的1、24和48小时观察涂抹部位皮肤反应,并评分。
3、实验结果:实验动物皮肤未出现任何红斑,红肿,发炎现象。
4、小结:根据《消毒技术规范》(1999)中皮肤刺激反应评分标准判定,本发明软膏剂对动物皮肤刺激强度属无刺激性。
实施例3:阴道粘膜刺激试验结果
1.试验方法:
实验动物检疫3天后,选用18只上述健康家兔,随机分为三组,每组各6只,分别为:空白对照、赋形剂对照、本发明美容霜。分别用适当大小的灭菌棉条浸以灭菌生理盐水和受试物置于赋形剂对照组和受试物组动物阴道内,与阴道粘膜接触6小时,24小时后处死动物。取出局部阴道组织,观察病变情况。
2、试验结果:阴道粘膜刺激试验结果
实施例4:皮肤过敏试验结果
用本发明美容霜,进行诱导和激发接触试验,在24小时和48小时后观察试验小鼠,均不见皮肤有红斑及水肿等现象,与阴性对照组无差异。结果表明,该膏剂对皮肤反应强度近于零,即无皮肤变态反应。
实施例5:长期毒性实验资料
1、实验方法
将豚鼠随机份成4组,每组15只。在豚鼠背部脊柱两侧将脱毛剂均匀涂上,使其脱毛范围约40平方厘米。洗净脱毛剂,观察24小时后每组豚鼠分别涂本发明眼霜0.2、0.4和0.8ml,分别含生药92、184和368mg,另一组涂溶媒0.8ml每日二次,连续30天,观察豚鼠的一般情况,实验结束后处死动物进行血液学、血液生化及病理学检查。
2、结果
上述三组用药豚鼠躯干去毛区,未见局部皮肤有水肿、充血、红斑、出血点及溃疡。用药组与对照组动物毛发色泽、摄食、四肢活动等对照组无明显差异,血液生化检查,用药组与对照组均在正常范围。病理组织学检查,实验各组心、肝、肾及局部皮肤均未见明显病变。提示,本发明中药面霜长期用药对局部皮肤及全身重要脏器均未见明显的毒性作用。
药理学实验
一、本发明的微循环实验方法:
1、材料与方法:取50只小鼠,随机分成5组,每组10只(雌雄各半),对照组每鼠右耳涂生理盐水少许;阳性对照组每鼠右耳给予市售欧莱雅复颜抗皱紧致滋润晚霜30ml,受试组为本发明外用美容膏30ml。15min后腹腔注射0.1%戊巴比妥钠0.1ml/10g麻醉动物,随后尾静脉注射0.1%肾上腺素0.1mL/10g,立即观察小鼠右耳微动静脉口径(μm)及0.2mm2毛细血管网点数.t检验处理实验数据.
2结果与讨论
2.1.对微循环的影响
与对照组相比,受试组1对小鼠毛细血管开放数有明显增多(P<0.01);受试组2对微静脉口径和毛细血管开放数有显著增加(P<0.01);受试组3对小鼠微动、静脉口径及毛细血管开放数皆有增加(P<0.01);说明受试药能改善微循环,有活血化瘀作用(表1)。
表1、本发明美容膏对小鼠微动、静脉口径及毛细血管开放数的影响
二、对巴豆油所致小鼠耳廓肿胀的影响
取健康小鼠30只,随机分成3组,即空白对照组、市售欧莱雅复颜抗皱紧致滋润晚霜阳性对照组、本发明美容膏,每组10只,雌雄各半,阳性对照组和本发明组分别涂抹,空白对照组涂抹等剂量的生理盐水,连续给药7天,于末次给药后0.5小时,在小鼠左耳内外测涂巴豆油致炎剂(2%巴豆油,20%无水乙醇,5%蒸馏水,73%乙醚)0.1ml致炎,致炎后4小时用打孔器(孔径6mm)打下左、右耳片,称重,以左右耳片重量差作为肿胀程度,结果见表2。
表2对巴豆油所致小鼠耳廓肿胀的影响(X±SD)
注:与对照组比较:**P<0.01;与阳性对照组比较:#P<0.05;由上表实验结果可以看出,本发明具有更好的消肿药理作用。
三.对角叉菜胶所致大鼠足跖肿胀的影响
取健康大鼠30只,体重180-220g,随机分成空白对照组、欧莱雅复颜抗皱紧致滋润晚霜阳性对照组、本发明美容膏。每组10只,雌雄各半,分笼饲养。阳性对照组和本发明药物组分别每日涂抹0.2g,空白对照组给予同剂量的生理盐水涂抹,连续给药7天,于末次给药后30分钟,分别在大鼠右后足跖皮下注射1%角叉菜胶混悬液0.1ml/只致炎,分别于致炎前和致炎后15、30、60、120、240分钟测大鼠右后足跖的周长,并计算肿胀率【肿胀率=(致炎后足跖周长-致炎前足跖周长)/致炎前足跖周长×100%】;结果见表3。
表3对角叉菜胶所致大鼠足跖肿胀的影响(X±SD)
注:与对照组比较:**P<0.01;与阳性对照组比较:#P<0.05;由上表实验结果可以看出,本发明药物组具有更好的抗皱平肌肉,消除肌肤纹理的药理作用。
3讨论
临床试验
说明:我院于2014年9月-2015年9月,使用自制抗皱霜、对面部皱纹,颈部皱纹、眼角皱纹,疗效显著,现报道如下。
临床资料:临床选取面部皱纹,眼角皱纹、颈部皱纹明显者80例。全部为女性。年龄35-55岁,平均41岁;未婚者20例,已婚者60例,已育者65例;病程6个月-20年,平均9.58年;教育水平大学文化45人,白领、教师、干部、科室人员23例,其他人员12例。自述经常熬夜加班43例,遗传35倒,失眠20例,每日保养皮肤者66人,激光治疗祛皱25人。临床分为治疗组40例,对照组40例。
治疗方法:治疗组采用自制中药美容膏,方用:益母草30g,积雪草12g,黄芪12g,玉竹13g,葛根12g,丹参12g,黄精10g,天花粉11g,红花13g,白芍12g,白芨11g,薄荷12g,白茯苓12g,白蔹11g,白芷12g,月季花12g,金盏花12g,当归13g,杏仁12g,玫瑰花13g,天竺葵12g,合欢皮11g,白术12g,冬瓜皮12g,按实施例2的方法制作成面霜。
取对照组,每组50例,分别使用市售的欧莱雅复颜抗皱紧致滋润晚霜。
操作过程:进行时人员平卧床上,用3%双氧水清洁面部,用负离子喷雾器喷雾面部,同时配合经络穴位按摩十二法进行面部按摩,眼周局部做重点按摩,时间约10min.后取晚霜,均匀涂于脸部,注意不要弄进眼睛,可适当按摩10-15分钟。每日一次,15天一疗程。疗程结束后,每月随访1次,连续随访3个月。治疗期间嘱病人少食辛辣,注意休息,并停用其它美容护理品。
疗效标准
效果明显:治疗2疗程后,脸部肌肤紧致,脸部皱纹,下巴紧致、眼角皱纹明显淡化,且疗效维持1个月以上,脸部肌肤略有改善紧致,嘴角皱纹,下巴皱纹改善,眼疲劳缓解;有效:眼袋、眼角皱纹明显变淡,消退50%以上,病人自觉满意,睡眠质量好;或治疗期间眼袋消失,但随访中睡眠不好,加班又有复发;无效:下巴、嘴角皱纹无明显变化,眼袋、眼角皱纹改变不明显或无变化;或曾消退50%以上,但随访中明显加重,试验人员不满意。
治疗结果:治疗组总有效率与各对照组比较,差别均有显著性(P<0.01),说明自制美容膏疗效明显优于市售紧致抗皱产品。详见表1
表13组疗效对比表(%)
注:与其他各组比较*P<0.01
随访结果随访发现,按摩者强于不按摩的人士。坚持使用效果明显。本发明公开了一种中药抗皱组合物,由中药成份组成。其中,当归促进皮肤代谢、活血亮肤;白芷、白茯苓、杏仁美白润肤;白芨紧实除皱;月季花有美白收敛生肌、促进细胞再生及疤痕愈合的功效,是美白护肤的珍品;积雪草能抗老化、紧实毛孔、除细纹的功效,也是美容抗老的圣品。有活血亮肤、美白防皱的功效,适用于中老年,衰老松弛、皱纹密布的皮肤。
Claims (10)
1.一种抗皱美容膏制作方法,其特征在于,所述美容膏制作方法包括以下步骤:
a.益母草的制作,萃取,作为组分1;
b.取薄荷、白术、白芷与白芨用蒸馏法汽化成结晶,粉碎过细筛待用,作为组分2;
c.将其余原料药用乙醇提取2次,合并浓缩提取液,作为组分3;
d.将组分1、组分2与组分3混合后加基质蜂胶调和,杀菌装罐后冷藏。
2.根据权利要求1所述益母草抗皱美容膏的制作方法,其特征在于,所述步骤a中,在夏季生长茂盛花未全开时采摘,将采摘好的益母草晒干,切碎,过80-100目筛。
3.根据权利要求1所述益母草抗皱美容膏的制作方法,其特征在于,所述步骤a中,进一步包括萃取的步骤,将切碎的益母草置于有盖不锈钢桶内,加70%乙醇液,质量为粗粉的0.8-1倍,搅拌均匀,湿润密闭放置1小时以上,使充分膨胀;将渗漉筒底部滤板用纱布袋包裹铺平后再将湿润膨胀后的药物样品拌松弄散,然后用不锈钢勺盛粉,均匀的装入渗漉筒,装10-12厘米厚,用T型棒压匀,再按上述操作,一层一层的装入,适当加压,药粉填装不得超过渗漉筒的2/3高处;药粉面上盖不锈钢孔板压牢,打开渗漉筒下面的放料阀,并放一容器,然后缓缓加入70%乙醇液;待排出药粉粉粒之间的空气,并有乙醇流出约20L左右,关闭放料阀,盖上漉筒、浸渍24小时,然后开放料阀进行渗漉,控制渗漉速度一般为1000g药材每分钟流出2~3ml,滤液放入贮液缸内,并将排空时的乙醇液倒入贮液缸;将渗滤液合并静置,加热浓缩至膏状,静置备用,成组分1。
4.根据权利要求1所述益母草抗皱美容膏的制作方法,其特征在于,所述步骤b中,取薄荷、白术、白芷与白芨用蒸馏法汽化成结晶,粉碎过120-150目细筛待用,作为组分2。
5.根据权利要求1所述益母草抗皱美容膏的制作方法,其特征在于,所述步骤c中,将所述其余原料加入占其质量5-10倍量的乙醇浸泡4-6小时,加热提取2次,每次1-2小时,合并提取液,静置后去上清液,然后100-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.25的滤液,静置放入双效真空浓缩器中混合,先将滤液浓缩至80℃时相对密度为1.32的浓缩液,再置入0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含0.1g浸膏,作为组分3。
6.根据权利要求1所述益母草抗皱美容膏的制作方法,其特征在于,所述步骤d中,将上述步骤提取的三种组分混合,搅拌均匀,加热,调和基质,基质选用蜂胶,紫外线杀菌装瓶冷藏。
7.一种抗皱美容膏,其特征在于,所述美容膏中包括以下重量份数的原料药:益母草10~50份,积雪草10~20份,黄芪10~20份,玉竹10~20份,葛根10~20份,丹参10~20份,黄精10~20份,天花粉10~20份,红花10~20份,白芍10~20份,白芨10~20份,薄荷10~20份,白茯苓10~20份,白蔹10~20份,白芷10~20份,月季花10~20份,金盏花10~20份,当归10~20份,杏仁10~20份,玫瑰花10~20份,天竺葵10~15份,合欢皮10~15份,白术10~15份,冬瓜皮10~15份。
8.根据权利要求7所述益母草抗皱美容膏,其特征在于,所述美容膏中包括以下重量份数的原料药:益母草10~30份,积雪草10~15份,黄芪10~15份,玉竹10~15份,葛根10~15份,丹参10~15份,黄精10~15份,天花粉10~15份,红花10~15份,白芍10~15份,白芨10~15份,薄荷10~15份,白茯苓10~15份,白蔹10~20份,白芷10~20份,月季花10~20份,金盏花10~20份,当归10~20份,杏仁10~20份,玫瑰花10~20份,天竺葵10~15份,合欢皮10~15份,白术10~15份,冬瓜皮10~15份。
9.根据权利要求7所述益母草抗皱美容膏,其特征在于,所述美容膏中包括以下重量份数的原料药:益母草15~40份,积雪草10~20份,黄芪10~20份,玉竹10~20份,葛根10~20份,丹参10~20份,黄精10~20份,天花粉10~20份,红花10~20份,白芍10~20份,白芨10~20份,薄荷10~20份,白茯苓10~20份,白蔹10~15份,白芷10~15份,月季花10~15份,金盏花10~15份,当归10~15份,杏仁10~15份,玫瑰花10~15份,天竺葵10~15份,合欢皮10~15份,白术10~15份,冬瓜皮10~15份。
10.根据权利要求7~9中任一项所述抗皱美容膏的使用方法,其特征在于,本抗皱美容膏不含防腐剂,必须冷藏,每次临睡前洁面后,将抗皱膏均匀涂抹于脸部,并用中指指肚在脸部按摩15-20分钟,至其充分吸收后,第二天早起洗去即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511030395.0A CN105663700A (zh) | 2015-12-31 | 2015-12-31 | 抗皱美容膏制作方法及其美容膏 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511030395.0A CN105663700A (zh) | 2015-12-31 | 2015-12-31 | 抗皱美容膏制作方法及其美容膏 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105663700A true CN105663700A (zh) | 2016-06-15 |
Family
ID=56298368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201511030395.0A Withdrawn CN105663700A (zh) | 2015-12-31 | 2015-12-31 | 抗皱美容膏制作方法及其美容膏 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105663700A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108785207A (zh) * | 2018-08-10 | 2018-11-13 | 广州碧雅医疗保健科技有限公司 | 一种含中药复方成分的抗衰老驻颜护肤组合物及护肤品 |
CN112425785A (zh) * | 2020-11-25 | 2021-03-02 | 湖南宜贝生物科技有限公司 | 一种具有美容养颜功效的组合物及其制备方法和应用 |
-
2015
- 2015-12-31 CN CN201511030395.0A patent/CN105663700A/zh not_active Withdrawn
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108785207A (zh) * | 2018-08-10 | 2018-11-13 | 广州碧雅医疗保健科技有限公司 | 一种含中药复方成分的抗衰老驻颜护肤组合物及护肤品 |
CN112425785A (zh) * | 2020-11-25 | 2021-03-02 | 湖南宜贝生物科技有限公司 | 一种具有美容养颜功效的组合物及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102049008B (zh) | 一种治疗黄褐斑的中药组合物及其制备方法 | |
CN102988264B (zh) | 银杏叶祛斑美白霜及其制备方法 | |
CN102845571B (zh) | 一种桑叶祛斑养颜茶及其制备方法 | |
CN105496917A (zh) | 一种积雪草抗皱面霜及其制备方法 | |
CN103751635A (zh) | 一种治疗黄褐斑的中药面膜及其制备方法 | |
CN105342908A (zh) | 一种缓解皱纹的积雪草中药美容抗皱膏及其制备方法 | |
CN103751709A (zh) | 一种治疗黄褐斑的中药组合物及其制备方法 | |
CN105267477A (zh) | 一种清肝明目的丹参叶保健茶及其制备方法 | |
CN105616318A (zh) | 一种抗皱紧肤的积雪草中药面膜及其制备方法 | |
CN103735835A (zh) | 一种治疗少白头的中药制剂及其制备方法 | |
CN104922051A (zh) | 一种缓解眼角皱纹眼袋的中药眼霜及其制备方法 | |
CN105362697A (zh) | 一种祛斑养颜的白芷中药面膜及其制备方法 | |
CN106074959A (zh) | 一种缓解黑眼圈的中药组合物及其制备方法 | |
CN104473153B (zh) | 一种美容养颜的桑葚口服液及其制备方法 | |
CN105342954A (zh) | 一种具有活肤化瘀去黄去斑的中药面膜及其制备方法 | |
CN105663700A (zh) | 抗皱美容膏制作方法及其美容膏 | |
CN105616984A (zh) | 一种益母草去皱美容膏及其制备方法 | |
CN105534854A (zh) | 一种祛除鱼尾纹及眼袋的眼霜及其制备方法 | |
CN105919907A (zh) | 中药眼霜制作方法及其眼霜 | |
CN105616317A (zh) | 一种缓解眼部皱纹、眼袋的积雪草眼霜及其制备方法 | |
CN105920379A (zh) | 一种缓解眼袋的中药眼霜及其制备方法 | |
CN104958235A (zh) | 一种缓解眼疲劳黑眼圈的中药眼膜及其制备方法 | |
CN102091254B (zh) | 一种用于面部整容后消肿的中药组合物及其制备方法 | |
CN105362807A (zh) | 一种具有活肤化瘀去黄去斑的中药面膜 | |
CN106806725A (zh) | 一种美容美白的桑葚面膜 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160615 |